Roche
Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.

Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.
WASHINGTON — The Internal Revenue Service announced today that it has successfully resolved a transfer pricing dispute with Glaxo SmithKline Holdings (Americas) Inc. & …
NEW YORK — Former Bank of America broker Theodore Sihpol III was acquitted yesterday of 29 counts, including a top charge of grand larceny, at a trial related to after-hours mutual-funds trading…